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We thank Richter and Vaezi (1) for their perspectives on our recent publication of the ANMS/ACG 
recommendations for successful reopening of motility laboratories in the coronavirus disease (COVID)-
19 era, and we are encouraged that our recommendations have proved helpful (2). Similar to the 
experiences of Richter and Vaezi, most of our motility centers are up to full capacity in performing 
motility studies. Among centers that have performed routine COVID-19 testing, our positivity rates have 
been similarly low (0.2%–1.5%), but all positive cases were encountered in asymptomatic individuals. 
The pandemic continues to evolve, with varying community positivity rates around the country and 
varying local and institutional guidelines for testing and screening. Clearly, a one-size-fits-all approach is 
not going to be optimal. 
We acknowledge that we are now learning more about the risk of transmission of the COVID-19 virus 
during endoscopy and motility laboratory procedures, and the risk seems to be low (1,3). Guidelines for 
endoscopy have evolved, and many gastrointestinal societies worldwide recommend careful screening 
for symptoms, contact, and temperature before confirmation of the endoscopy appointment in lieu of 
routine testing; some also recommend follow-up with the patient 14 days after the procedure (4). The 
approach outlined by Richter and Vaezi falls along similar concepts, and their experiences demonstrate 
that screening without routine testing has value as a successful approach to running a motility 
laboratory. 
There are 3 factors that need additional consideration. First, routine symptom and contact screening 
over the telephone requires time and personnel, which could offset any cost savings from not 
performing COVID-19 tests. In most motility centers, motility personnel perform this additional 
screening, and one could make the argument that their time is better spent performing motility studies. 
Second, local and institutional guidelines have to be taken into consideration because some institutions 
continue to require testing for COVID-19 before invasive and endoscopic procedures (5). Finally, one has 
to account for the fact that inserting a nasal probe in an awake patient might result in sputtering, 
retching, sneezing, and, more importantly, coughing, all of which increase the risk of aerosolization (6). 
This can be of risk to the operator performing manometry and catheter-based reflux monitoring 
procedures, especially if the local prevalence of asymptomatic COVID-19 infections is high (7). 
Currently, it might be reasonable to proceed with a symptom-and-contact screening approach, 
complemented with temperature checks, as long as the above-outlined factors are taken into 
consideration. If this approach is pursued without COVID-19 testing, we recommend use of full personal 
protective equipment, including gloves, face shield or goggles, and gown, during motility procedures 
with risk of aerosolization, particularly esophageal motility and reflux monitoring studies. As our 
understanding of the COVID-19 infection evolves, there will no doubt be further adjustments to 
published recommendations to enhance safety of both motility laboratory personnel and the patients 
they serve. 
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